Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of Antidepressant

• Status: Unknown status
• Trial end date: 2005-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the safety and efficacy of risperidone augmentation in patients who have failed to respond or only partially responded to an adequate trial of an antidepressant.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rhode Island Hospital
• Collaborators: Emory University; Janssen Pharmaceutica N.V., Belgium
• Treatments: Antidepressive Agents; Risperidone

Criteria

Inclusion Criteria:

• patients with major depression or partially remitted depression

• currently receiving an adequate trial of an antidepressant

Exclusion Criteria:

• diagnosis of bipolar I or bipolar II disorder

• psychotic features

• substance dependence or abuse in the past three months